Top Markets
Coin of the day
Rekah Pharmaceutical Industry Ltd. Rekah Pharmaceutical Industry Ltd.

Rekah Pharmaceutical Industry Ltd.

REKA
Rank in Stocks #39665
Rekah Pharmaceutical Industry Ltd., established in 1941 and headquartered in... Rekah Pharmaceutical Industry Ltd., established in 1941 and headquartered in Holon, Israel, specializes in the production, marketing, distribution, and sale of a broad spectrum of healthcare items across Israel. The company's offerings include both prescription and over-the-counter medicines, dermo-cosmetic products, vitamins, and nutritional supplements. Its extensive portfolio comprises approximately 280 distinct pharmaceutical drugs used in various medical sectors. These encompass steroid tablets, antibiotics (such as penicillin and cephalosporin), eye drops and ointments for allergies, infections, and dryness, baby products, and dermatological treatments.
Share Price
$3.40
Market Cap
$388.12K
Change (1 day)
-1.50%
Change (1 year)
-4.41%
Country
IL
Trade Rekah Pharmaceutical Industry Ltd. (REKA)

Category

Operating Margin for Rekah Pharmaceutical Industry Ltd. (REKA)
Operating Margin as of 2026 TTM: 0.00%
According to Rekah Pharmaceutical Industry Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Rekah Pharmaceutical Industry Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
23.18% -
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.